ZBH logo

Zimmer Biomet Holdings (ZBH) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$525.50 M
+$109.70 M+26.38%

December 31, 2024


Summary


Performance

ZBH Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherZBHbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$525.50 M
-$43.50 M-7.64%

December 31, 2024


Summary


Performance

ZBH Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherZBHbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

ZBH Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+26.4%-7.6%
3 y3 years+39.0%-3.6%
5 y5 years-14.9%-49.6%

ZBH Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+39.9%-7.6%+79.9%
5 y5-year-34.5%+39.9%-78.4%+79.9%
alltimeall time-64.0%-100.0%-94.0%+3247.1%

Zimmer Biomet Holdings Cash And Cash Equivalents History

DateAnnualQuarterly
Dec 2024
$525.50 M(+26.4%)
$525.50 M(-7.6%)
Sep 2024
-
$569.00 M(+35.4%)
Jun 2024
-
$420.10 M(+6.9%)
Mar 2024
-
$393.00 M(-5.5%)
Dec 2023
$415.80 M(+10.7%)
$415.80 M(+42.3%)
Sep 2023
-
$292.10 M(-8.7%)
Jun 2023
-
$319.80 M(-3.1%)
Mar 2023
-
$330.20 M(-12.1%)
Dec 2022
$375.70 M(-0.6%)
$375.70 M(-31.1%)
Sep 2022
-
$545.40 M(+41.1%)
Jun 2022
-
$386.40 M(-11.3%)
Mar 2022
-
$435.80 M(+15.3%)
Dec 2021
$378.10 M(-52.9%)
$378.10 M(-58.9%)
Sep 2021
-
$919.60 M(-11.8%)
Jun 2021
-
$1.04 B(+43.9%)
Mar 2021
-
$724.30 M(-9.7%)
Dec 2020
$802.10 M(+29.8%)
$802.10 M(-17.1%)
Sep 2020
-
$967.30 M(+35.6%)
Jun 2020
-
$713.40 M(-70.7%)
Mar 2020
-
$2.43 B(+293.9%)
Dec 2019
$617.90 M(+13.8%)
$617.90 M(+20.6%)
Sep 2019
-
$512.50 M(+27.1%)
Jun 2019
-
$403.10 M(-31.3%)
Mar 2019
-
$586.80 M(+8.1%)
Dec 2018
$542.80 M(+3.5%)
$542.80 M(+3.5%)
Sep 2018
-
$524.60 M(+9.0%)
Jun 2018
-
$481.20 M(-72.7%)
Mar 2018
-
$1.77 B(+236.7%)
Dec 2017
$524.40 M(-17.3%)
$524.40 M(+9.1%)
Sep 2017
-
$480.80 M(+6.8%)
Jun 2017
-
$450.00 M(-56.7%)
Mar 2017
-
$1.04 B(+63.9%)
Dec 2016
$634.10 M(-56.5%)
$634.10 M(+33.4%)
Sep 2016
-
$475.30 M(-51.3%)
Jun 2016
-
$976.30 M(-2.1%)
Mar 2016
-
$996.80 M(-31.7%)
Dec 2015
$1.46 B(+34.7%)
$1.46 B(-0.5%)
Sep 2015
-
$1.47 B(+3.0%)
Jun 2015
-
$1.42 B(-83.8%)
Mar 2015
-
$8.79 B(+711.7%)
Dec 2014
$1.08 B(+0.2%)
$1.08 B(+12.0%)
Sep 2014
-
$967.30 M(-0.1%)
Jun 2014
-
$968.70 M(+9.7%)
Mar 2014
-
$882.70 M(-18.3%)
Dec 2013
$1.08 B
$1.08 B(+17.8%)
Sep 2013
-
$917.40 M(+29.2%)
Jun 2013
-
$709.90 M(+8.1%)
DateAnnualQuarterly
Mar 2013
-
$657.00 M(-25.7%)
Dec 2012
$884.30 M(+15.1%)
$884.30 M(+10.3%)
Sep 2012
-
$801.50 M(+23.1%)
Jun 2012
-
$651.00 M(-3.4%)
Mar 2012
-
$674.00 M(-12.3%)
Dec 2011
$768.30 M(+14.9%)
$768.30 M(+38.9%)
Sep 2011
-
$553.00 M(-11.4%)
Jun 2011
-
$624.10 M(+8.4%)
Mar 2011
-
$575.60 M(-13.9%)
Dec 2010
$668.90 M(-3.3%)
$668.90 M(-29.9%)
Jun 2010
-
$953.70 M(+16.1%)
Mar 2010
-
$821.20 M(+18.7%)
Dec 2009
$691.70 M(+225.4%)
$691.70 M(+57.3%)
Sep 2009
-
$439.70 M(+58.5%)
Jun 2009
-
$277.50 M(+30.4%)
Mar 2009
-
$212.80 M(+0.1%)
Dec 2008
$212.60 M(-54.2%)
$212.60 M(-60.8%)
Sep 2008
-
$542.40 M(+39.8%)
Jun 2008
-
$388.10 M(-18.5%)
Mar 2008
-
$476.00 M(+2.6%)
Dec 2007
$463.90 M(+74.6%)
$463.90 M(+48.2%)
Sep 2007
-
$313.00 M(-12.7%)
Jun 2007
-
$358.70 M(+10.0%)
Mar 2007
-
$326.00 M(+22.7%)
Dec 2006
$265.70 M(+13.9%)
$265.70 M(-3.6%)
Sep 2006
-
$275.60 M(-17.9%)
Jun 2006
-
$335.80 M(-16.8%)
Mar 2006
-
$403.80 M(+73.2%)
Dec 2005
$233.20 M(+50.8%)
$233.20 M(+154.0%)
Sep 2005
-
$91.80 M(+16.5%)
Jun 2005
-
$78.80 M(+38.2%)
Mar 2005
-
$57.00 M(-63.1%)
Dec 2004
$154.60 M(+99.5%)
$154.60 M(+241.3%)
Sep 2004
-
$45.30 M(-41.1%)
Jun 2004
-
$76.90 M(-29.3%)
Mar 2004
-
$108.70 M(+40.3%)
Dec 2003
$77.50 M(+393.6%)
$77.50 M(-56.2%)
Sep 2003
-
$177.00 M(+53.9%)
Jun 2003
-
$115.00 M(+244.3%)
Mar 2003
-
$33.40 M(+112.7%)
Dec 2002
$15.70 M(-14.7%)
$15.70 M(-24.5%)
Sep 2002
-
$20.80 M(-21.2%)
Jun 2002
-
$26.40 M(+26.9%)
Mar 2002
-
$20.80 M(+13.0%)
Dec 2001
$18.40 M(>+9900.0%)
$18.40 M(-21.4%)
Sep 2001
-
$23.40 M
Dec 2000
$0.00
-

FAQ

  • What is Zimmer Biomet Holdings annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Zimmer Biomet Holdings?
  • What is Zimmer Biomet Holdings annual cash & cash equivalents year-on-year change?
  • What is Zimmer Biomet Holdings quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Zimmer Biomet Holdings?
  • What is Zimmer Biomet Holdings quarterly cash and cash equivalents year-on-year change?

What is Zimmer Biomet Holdings annual cash & cash equivalents?

The current annual cash & cash equivalents of ZBH is $525.50 M

What is the all time high annual cash & cash equivalents for Zimmer Biomet Holdings?

Zimmer Biomet Holdings all-time high annual cash & cash equivalents is $1.46 B

What is Zimmer Biomet Holdings annual cash & cash equivalents year-on-year change?

Over the past year, ZBH annual cash & cash equivalents has changed by +$109.70 M (+26.38%)

What is Zimmer Biomet Holdings quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of ZBH is $525.50 M

What is the all time high quarterly cash and cash equivalents for Zimmer Biomet Holdings?

Zimmer Biomet Holdings all-time high quarterly cash and cash equivalents is $8.79 B

What is Zimmer Biomet Holdings quarterly cash and cash equivalents year-on-year change?

Over the past year, ZBH quarterly cash and cash equivalents has changed by -$43.50 M (-7.64%)